🔗 Share this article

While the United States undertakes historic changes to its vaccine schedules, an unexpected name has emerged in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who initially gained attention by casting doubt on COVID-19 shots throughout the pandemic and has focused upon possible fatalities following Covid immunization in her recent time at the FDA.

Scheduled Shifts to Childhood Immunization Program

Agency leaders had intended to reveal radical revisions to the pediatric vaccine schedule recently, synchronizing the US with the Danish national calendar, it is understood – a substantial departure that would put the US at odds with many the international standard with no evidence for public health gain. The announcement has been postponed until the next year.

Instead of the top vaccines chief, Høeg is scheduled to present at the event. She was newly appointed temporary leader of the FDA’s CDER, the fifth appointee to run the center this year.

A New Direction at the Agency

This interim role might represent a tighter collaboration between the drug and vaccine divisions as Høeg and Prasad strengthen their influence at the FDA – and it signals a greater focus upon reevaluating previously authorized vaccines at the FDA.

Høeg has repeatedly called for halting certain childhood vaccine recommendations in the US in order to be more like Denmark, a nation with universal health coverage and a number of inhabitants approximately the size of Wisconsin’s.

To date statements, she has continued to focus on immunizations – traditionally the purview of Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than medication approval.

Concerns Over Qualifications

Høeg has no obvious experience in drug development, regulation or leadership, which has been standard for past heads of the CBER. She has served at the FDA as a top consultant to the FDA chief and the vaccine center since earlier this year.

“She doesn’t seem to have the necessary background” for overseeing the pharmaceutical oversight division, remarked a neurologist and psychiatrist. “She’s never run a randomized controlled trial. She has no expertise in leading a large organization. She is not an expert in industry regulation.”

Previous commissioners of the center would “understand regulatory frameworks and the research of drug development”, said a former acting FDA commissioner. “Objectively, she lacks the type of experience that prior appointees who ran CBER have had.”

The drug center has an immense range of responsibilities at the FDA, Woodcock pointed out.

“Everybody just focuses on the new drug program, but the off-patent medication office authorizes numerous generic medications. There’s a biosimilars division, OTC medication office and other areas, and each of these have to be looked after,” Dr. Woodcock said. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Additionally, a substantial leadership element to the job, which oversees in excess of 5,000 employees. “It is a enormous administrative position, if you execute it properly,” Woodcock concluded.

Official Statement and Disputed Programs

In response to inquiries about Høeg’s credentials and whether this appointment represents increased cooperation among FDA leaders on vaccines, a representative said that the “questions are based on flawed premises”.

“Her experience aligns with the responsibilities of her position,” the official explained, citing the period Høeg spent advising the FDA commissioner on “pharmaceutical safety and oversight research, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Dr. Høeg assumes responsibility for the commissioner’s recently launched fast-track approval initiative, a contentious rapid medication authorization process that reportedly worried her preceding directors. “How are these medications being picked for this fast-track system? Who is making the choices?” Dr. Howard asked. “There’s a lot of confidentiality going on at the agency right now.”

In general, he remarked, “the FDA looks to be trending towards more relaxed regulations of pharmaceuticals, with the exception of vaccines.”

Established Track Record on Vaccines

Regarding immunizations, Dr. Høeg has a clearer, if problematic, history, some experts observe. She published a study using non-validated crowd-sourced reports to estimate the incidence of heart inflammation following Covid vaccination. She consulted for the Florida chief medical officer Joseph Ladapo, who reportedly have changed statistics to imply COVID-19 vaccines are more dangerous than they are.

Among her “desired changes” for the incoming government featured altering guidelines for recently developed shots and discontinuing “non-essential” vaccines, she remarked following the vote on a audio program. At the agency, Høeg has reportedly proposed preventing teenage boys from obtaining Covid vaccinations.

“She is an thorough true believer who starts off with her conclusions and tailors the evidence to retrofit the data in a very deceptive, untruthful way,” Dr. Howard stated.

Gaining Influence and a “Campaign of Retribution”

Høeg became part of fellow skeptics, {like|